HAE

NYSEStock

Haemonetics Corporation

$59.49-1.13 (-1.86%)

52-Week Range

$47.67

$87.16

Key Stats

Market Cap

2.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Volume

494.6K

Avg Volume

745.3K

Performance

+0.05%

-28.75%

+15.85%

YTD

-25.62%

-9.42%

-20.13%

-50.13%

Price Chart

ETF Exposure

HAE is held by 136 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.01%	58,763	$3.7M	$81.53B	0.03%
IUSG	iShares Core S&P U.S. Growth ETF	0.01%	22,668	$1.4M	$27.24B	0.04%
IWV	iShares Russell 3000 ETF	0.01%	13,781	$866K	$17.58B	0.20%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.01%	9,560	$602K	$12.10B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.01%	4,034	$269K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.01%	1,463,303	$97.5M	$2.10T	0.03%
IUSV	iShares Core S&P U.S. Value ETF	0.00%	15,579	$979K	$24.24B	0.04%
SCHB	Schwab U.S. Broad Market ETF	0.00%	26,981	$1.7M	$38.14B	0.03%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	754	$50K	$1.46B	0.24%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	331	$21K	$618.9M	0.12%
VT	Vanguard Total World Stock ETF	0.00%	35,144	$2.3M	$80.60B	0.06%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	16	$1K	$33.4M	0.34%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	31	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	26	$2K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	17	$1K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	13	$813	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	6	$361	$9.5M	0.12%
AFTY	Pacer CSOP FTSE China A50 ETF	0.00%	7,488	$687K	$4.3M	0.70%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	1,027	$65K	$2.84B	0.19%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	310	$19K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	895	$56K	$3.28B	0.20%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	2	$104	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	2	$129	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	11	$700	$30.3M	0.32%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	13	$844	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	23	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	26	$2K	$64.1M	0.11%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	5,550	$401K	$6.8M	0.60%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.00%	30	$2K	$163.7M	0.12%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	5,550	$401K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	5,550	$401K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	5,550	$401K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	5,550	$401K	$3.7M	0.70%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	101	$6K	$733.2M	0.20%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	4	$255	$61.4M	0.09%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	101	$6K	$1.43B	0.09%

PreviousPage 3 of 3

About HAE ETF Exposure

Haemonetics Corporation (HAE) is held by 136 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.8B, HAE is a widely held institutional stock. The stock currently trades at $59.49. Investors can gain exposure to HAE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HAE, sorted by portfolio weight.